Comparison of Postoperative, In-Hospital Outcomes After Complete Repair of Tetralogy of Fallot Between 22q11.2 Deletion Syndrome and Trisomy 21

Overview

Journal Pediatr Cardiol

Specialties Cardiology & Vascular Diseases
Pediatrics

Date 2021 Jul 31

PMID 34331082

Authors

Timothy E Nissen

Isabella Zaniletti

R Thomas Collins 2nd

Lawrence E Greiten

Parthak Prodhan

Paul M Seib

Elijah H Bolin

Affiliations

Soon will be listed here.

Abstract

22q11.2 deletion syndrome (22q11) and trisomy 21 (T21) are frequently associated with tetralogy of Fallot (TOF). We hypothesized that there are differences in postoperative length of stay (LOS) and occurrence of postoperative interventions after complete repair of TOF when comparing children with 22q11 to those with T21. Using the Pediatric Health Information System, we performed a retrospective cohort study of patients who underwent complete repair of TOF from 2004 to 2019. Three groups were identified: 22q11, T21, and controls (those without a coded genetic syndrome). Outcomes were postoperative LOS and composite occurrence (yes/no) of at least one postoperative intervention. Bivariate and multivariate comparisons were made among groups; odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using the control group as the comparator. There were 6924 subjects (n = 493 22q11, n = 455 T21, n = 5976 controls). In bivariate analysis, 22q11 was associated with a longer LOS compared to T21 (OR 2.37 [2.16, 2.60] vs. 1.25 [1.12, 1.39], p < 0.001), and 22q11 more often underwent postoperative intervention (OR 3.42 [CI 2.56, 4.57] vs. 1.38 [CI 0.91, 2.11]; p < 0.001). In multivariate analysis, 22q11 was also associated with longer LOS (adjusted OR 1.35 [1.26, 1.44] vs. 1.12 [1.04, 1.20]; p < 0.001), but there was no difference in the adjusted odds of postoperative intervention. Children with 22q11 are more likely to experience adverse outcomes after repair of TOF compared to those with T21; the differences are most pronounced for LOS.

References

Hoffman J, Kaplan S . The incidence of congenital heart disease. J Am Coll Cardiol. 2002; 39(12):1890-900. DOI: 10.1016/s0735-1097(02)01886-7. View

Amati F, Mari A, Digilio M, Mingarelli R, Marino B, Giannotti A . 22q11 deletions in isolated and syndromic patients with tetralogy of Fallot. Hum Genet. 1995; 95(5):479-82. DOI: 10.1007/BF00223856. View

Purifoy E, Spray B, Riley J, Prodhan P, Bolin E . Effect of Trisomy 21 on Postoperative Length of Stay and Non-cardiac Surgery After Complete Repair of Tetralogy of Fallot. Pediatr Cardiol. 2019; 40(8):1627-1632. DOI: 10.1007/s00246-019-02196-y. View

Takahashi K, Kido S, Hoshino K, Ogawa K, Ohashi H, Fukushima Y . Frequency of a 22q11 deletion in patients with conotruncal cardiac malformations: a prospective study. Eur J Pediatr. 1995; 154(11):878-81. DOI: 10.1007/BF01957496. View

Trainer A, Morrison N, Dunlop A, Wilson N, Tolmie J . Chromosome 22q11 microdeletions in tetralogy of Fallot. Arch Dis Child. 1996; 74(1):62-3. PMC: 1511583. DOI: 10.1136/adc.74.1.62. View

Anaclerio S, Di Ciommo V, Michielon G, Digilio M, Formigari R, Picchio F . Conotruncal heart defects: impact of genetic syndromes on immediate operative mortality. Ital Heart J. 2004; 5(8):624-8. View

Lahiri S, Gil W, Daria S, Joshua G, Parul J, Redmond B . Genetic abnormalities/syndromes significantly impact perioperative outcomes of conotruncal heart defects. Ann Pediatr Cardiol. 2020; 13(1):38-45. PMC: 6979035. DOI: 10.4103/apc.APC_51_19. View

Michielon G, Marino B, Formigari R, Gargiulo G, Picchio F, Digilio M . Genetic syndromes and outcome after surgical correction of tetralogy of Fallot. Ann Thorac Surg. 2006; 81(3):968-75. DOI: 10.1016/j.athoracsur.2005.09.033. View

Smith C, McCracken C, Thomas A, Spector L, Louis J, Oster M . Long-term Outcomes of Tetralogy of Fallot: A Study From the Pediatric Cardiac Care Consortium. JAMA Cardiol. 2018; 4(1):34-41. PMC: 6439686. DOI: 10.1001/jamacardio.2018.4255. View

10.

OBrien S, Jacobs J, Pasquali S, Gaynor J, Karamlou T, Welke K . The Society of Thoracic Surgeons Congenital Heart Surgery Database Mortality Risk Model: Part 1-Statistical Methodology. Ann Thorac Surg. 2015; 100(3):1054-62. PMC: 4728716. DOI: 10.1016/j.athoracsur.2015.07.014. View

11.

OBrien S, Jacobs J, Shahian D, Jacobs M, Gaynor J, Romano J . Development of a Congenital Heart Surgery Composite Quality Metric: Part 2-Analytic Methods. Ann Thorac Surg. 2018; 107(2):590-596. PMC: 6559355. DOI: 10.1016/j.athoracsur.2018.07.036. View

12.

Pasquali S, Shahian D, OBrien S, Jacobs M, Gaynor J, Romano J . Development of a Congenital Heart Surgery Composite Quality Metric: Part 1-Conceptual Framework. Ann Thorac Surg. 2018; 107(2):583-589. PMC: 6441562. DOI: 10.1016/j.athoracsur.2018.07.037. View

13.

Jacobs J, OBrien S, Hill K, Kumar S, Austin 3rd E, Gaynor J . Refining The Society of Thoracic Surgeons Congenital Heart Surgery Database Mortality Risk Model With Enhanced Risk Adjustment for Chromosomal Abnormalities, Syndromes, and Noncardiac Congenital Anatomic Abnormalities. Ann Thorac Surg. 2019; 108(2):558-566. DOI: 10.1016/j.athoracsur.2019.01.069. View

14.

Eicher P, McDonald-McGinn D, Fox C, Driscoll D, Emanuel B, Zackai E . Dysphagia in children with a 22q11.2 deletion: unusual pattern found on modified barium swallow. J Pediatr. 2000; 137(2):158-64. DOI: 10.1067/mpd.2000.105356. View

15.

Karpinski B, Maynard T, Fralish M, Nuwayhid S, Zohn I, Moody S . Dysphagia and disrupted cranial nerve development in a mouse model of DiGeorge (22q11) deletion syndrome. Dis Model Mech. 2013; 7(2):245-57. PMC: 3917245. DOI: 10.1242/dmm.012484. View

16.

KIRKPATRICK Jr J, DIGEORGE A . Congenital absence of the thymus. Am J Roentgenol Radium Ther Nucl Med. 1968; 103(1):32-7. DOI: 10.2214/ajr.103.1.32. View

17.

Lambert M, Arulselvan A, Schott A, Markham S, Crowley T, Zackai E . The 22q11.2 deletion syndrome: Cancer predisposition, platelet abnormalities and cytopenias. Am J Med Genet A. 2017; 176(10):2121-2127. DOI: 10.1002/ajmg.a.38474. View

18.

Wang X, Bryan C, LaMantia A, Mendelowitz D . Altered neurobiological function of brainstem hypoglossal neurons in DiGeorge/22q11.2 Deletion Syndrome. Neuroscience. 2017; 359:1-7. PMC: 5565681. DOI: 10.1016/j.neuroscience.2017.06.057. View

19.

Karlsson B, Gustafsson J, Hedov G, Ivarsson S, Anneren G . Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity. Arch Dis Child. 1999; 79(3):242-5. PMC: 1717691. DOI: 10.1136/adc.79.3.242. View

20.

Kivivuori S, Rajantie J, Siimes M . Peripheral blood cell counts in infants with Down's syndrome. Clin Genet. 1996; 49(1):15-9. DOI: 10.1111/j.1399-0004.1996.tb04318.x. View